Oxycodone naloxone prolonged release tablets (OXN)

DRUG2 trials

Sponsors

Mundipharma Research GmbH & Co KG

Conditions

Chronic OsteoarthritisPain

Phase 3

Oxycodone-naloxone Prolonged Release Tablets in Relieving Opioid-related Constipation

CompletedNCT00412100

Mundipharma Research GmbH & Co KGPain

Start: 2006-04-30End: 2008-09-30Updated: 2018-10-23

OXN PR Compared to OxyPR to Demonstrate Non-inferiority in Pain & Locomotor Function & Improvement in Symptoms of Constipation in OA Subjects

CompletedNCT00902837

Mundipharma Research GmbH & Co KGChronic Osteoarthritis

Start: 2009-05-31End: 2010-07-31Updated: 2018-10-22

Related Papers

Efficacy and safety of combined prolonged-release oxycodone and naloxone in the management of moderate/severe chronic non-malignant pain: results of a prospectively designed pooled analysis of two randomised, double-blind clinical trials.

2010-09-2957 citations